Myelodysplastic syndromes (Q61554): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Distúrbios hematopoiéticos clonais caracterizados por displasia e hematopoiese ineficaz em uma ou mais das linhas de células hematopoiéticas. A displasia pode vir acompanhada de aumento dos mieloblastos, porém com percentagem inferior a 20% na medula e no sangue, o que, segundo as diretrizes da OMS, é o limiar necessário para o diagnóstico de leucemia mieloide aguda. | |||
| description / en | description / en | ||
Clonal hematopoietic disorders characterised by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20% in marrow and blood, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukaemia. | |||
Revision as of 09:02, 14 August 2026
Clonal hematopoietic disorders characterised by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20% in marrow and blood, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukaemia.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1147802348 |
||
| English | Myelodysplastic syndromes |
Clonal hematopoietic disorders characterised by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20% in marrow and blood, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukaemia. |
